It inhibits GSH depletion, GPX4 degradation and lipid peroxidation, increases Nrf2, and inhibits 12/15-LOX (Xie et al., 2016
Fibrotic forms exhibit irregular and nodular appearance, while IgG4-related variants exhibit marked hypoechogenicity (Wu et al
Allow the medication to reach room temperature before injecting (15 to 30 minutes out of the fridge)
Recommended articles Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population Nsumbu JB, Makulo JR, Mutombo Tshiswaka T, Kisoka Lusunsi C, Nlombi Mbendi C Hepatic Medicine: Evidence and Research 2025, 17:27-37 Published Date: 15 July 2025 Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH) Van Kleef LA, Michel M, Alkhouri N, Brouwer WP, Schattenberg JM Drug Design, Development and Therapy 2026, 20:559331 Published Date: 17 March 2026